T1	Participants 89 144	patients with locally advanced resectable rectal cancer
T2	Participants 873 894	Thirty-seven patients
T3	Participants 363 394	Patients with stage II/III LARC
T4	Participants 1527 1537	6 patients
T5	Participants 1348 1359	17 patients
T6	Participants 1469 1480	13 patients
T7	Participants 1687 1716	patients with resectable LARC
